Skip to main content
. 2017 Jun 28;8(38):63311–63323. doi: 10.18632/oncotarget.18800

Figure 4. Pharmacokinetic and tissue distribution of Bufalin-BSA-NP in vivo.

Figure 4

(A, B, C) Bufalin concentration of Bufalin and Bufalin-BSA-NP at doses of 0.15 (A), 0.3 (B) and 0.6 (C) mg/kg, respectively; (D, E, F) tissue distribution of Bufalin and Bufalin-BSA-NP in vivo at 5, 15, and 45 min after a single dose of 0.3mg/kg. Values are expressed as mean ± standard error of mean; n = 5.